Robinson Capital Management’s Estrella Immunopharma ESLA Stock Holding History

Robinson Capital Management’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,610	Closed	-$137K	–	252
2023 Q2	$137K	Sell	12,610 -11,000	-47%	-$119K	0.06%	142
2023 Q1	$250K	Buy	+23,610	New	+$247K	0.12%	154

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Robinson Capital Management's ESLA Position: Q3 2023 in Review

Robinson Capital Management sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 12,610 shares — an estimated $137K sold.

Robinson Capital Management first reported a position in ESLA in Q1 2023 and held it in 2 quarters. The position peaked at $250K in Q1 2023. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

Robinson Capital Management reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
Robinson Capital Management sold 12,610 Estrella Immunopharma shares in Q3 2023, an estimated $137K.
Robinson Capital Management first reported a position in Estrella Immunopharma in Q1 2023 and held it in 2 quarters.
Robinson Capital Management's Estrella Immunopharma position peaked at $250K in Q1 2023.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on Robinson Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.